Weekender 12/12/14

Besides the holidays, the end of the year is a time to look back at your investments. News came across our desk this week noting that the pharmaceutical industry is seeing a higher return on its investments in research and development (R&D), something that will help continue to fuel our thriving industry. The New Jersey Economic Development Authority (EDA) also approved more than $17.6 million in Angel Investor Tax Credit investments to support four New Jersey emerging technology companies, including BioNJ Member Agile Therapeutics, Aucta Pharmaceuticals and ElectroCore.

Click here to read this week’s Weekender.